Question 1

What is BASILIXIMAB used for?

Accepted Answer

BASILIXIMAB (brand name Simulect) is a Other indicated for USP (MODIFIED), and corticosteroids. The efficacy of Simulect for the prophylaxis of acute rejection in recipients of other solid organ allografts has not been demonstrated..

Question 2

How does BASILIXIMAB work?

Accepted Answer

BASILIXIMAB works through the following mechanism: Pharmacodynamics Complete and consistent binding to IL-2Rα in adults is maintained as long as serum Simulect levels exceed 0.2 mcg/mL. As concentrations fall below this threshold, the IL-2Rα sites are no longer fully bound and the number of T-cells expressing unbound IL-2Rα returns to pretherapy values within 1-2 weeks. The relationship between serum concentration and receptor saturation was assessed in 13 pediatric patients and was similar to that characterized in adult renal transplantation pa.

Question 3

What are the most common side effects of BASILIXIMAB?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for BASILIXIMAB. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is BASILIXIMAB the same as Simulect?

Accepted Answer

Simulect is a brand name for BASILIXIMAB. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

BASILIXIMAB

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations